EGFR Testing for Metastatic Non-Small Cell Lung Cancer with Jonathan W. Riess, MD, MS: Case 1

EGFR Testing for Metastatic Non-Small Cell Lung Cancer with Jonathan W. Riess, MD, MS

EP. 1: Molecular Testing for NSCLC

October 11th 2016

EP. 2: How is Molecular Testing Used to Select Upfront Therapy in Patients with EGFR Mutations?

October 11th 2016

EP. 3: CASE 1: A 44-year-old Female Diagnosed with Relapsed Stage IV Adenocarcinoma

October 11th 2016

EP. 4: What is the Rationale for Repeat Molecular Testing at Progression?

October 11th 2016

EP. 5: How Will the Availability of Liquid Biopsy Change the Paradigm of Genetic Testing in the Setting of Metastatic Lung Cancer?

October 11th 2016

EP. 6: How Has the Availability of Osimertinib Changed the Treatment Paradigm for Repeat Molecular Testing at Progression?

October 11th 2016

EP. 7: Safety and Efficacy Data for Osimertinib

October 11th 2016

Advertisement

Advertisement